Stefan Lutz - 07 Nov 2025 Form 3 Insider Report for CODEXIS, INC. (CDXS)

Role
CSO
Signature
/s/ Georgia Erbez, as Attorney-in-Fact for Stefan Lutz
Issuer symbol
CDXS
Transactions as of
07 Nov 2025
Net transactions value
$0
Form type
3
Filing time
17 Nov 2025, 17:10:31 UTC
Next filing
08 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lutz Stefan CSO C/O CODEXIS, INC., 200 PENOBSCOT DRIVE, REDWOOD CITY /s/ Georgia Erbez, as Attorney-in-Fact for Stefan Lutz 17 Nov 2025 0002094828

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CDXS Common Stock 143,460 07 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 25,500 $11.79 Direct F2
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 8,800 $11.79 Direct F3
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 10,000 $26.16 Direct F4
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 16,006 $26.16 Direct F3
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 13,000 $19.39 Direct F5
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 17,000 $19.39 Direct F3
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 112,500 $5.44 Direct F6
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 209,400 $3.05 Direct F7
holding CDXS Stock Option (Right to Buy) 07 Nov 2025 Common Stock 105,000 $4.37 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 53,266 Restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit.
F2 Option vests with respect to 25% of the shares subject thereto on May 1, 2021, with 1/36th of the shares vesting monthly thereafter.
F3 The option is fully vested and exercisable.
F4 Option vests with respect to 25% of the shares subject thereto on February 16, 2022, with 1/36th of the shares vesting monthly thereafter.
F5 Option vests with respect to 25% of the shares subject thereto on February 7, 2023, with 1/36th of the shares vesting monthly thereafter.
F6 Option vests with respect to 25% of the shares subject thereto on February 21, 2024, with 1/36th of the shares vesting monthly thereafter.
F7 Option vests with respect to 1/3 of the shares subject thereto on January 1, 2025, with 1/24th of the shares vesting monthly thereafter.
F8 Option vests with respect to 25% of the shares subject thereto on February 5, 2026, with 1/36th of the shares vesting monthly thereafter.

Remarks:

Exhibit 24.1 - Power of Attorney